121 related articles for article (PubMed ID: 15077700)
1. Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities.
Anderson PJ; Wood SJ; Francis DE; Coleman L; Warwick L; Casanelia S; Anderson VA; Boneh A
Dev Med Child Neurol; 2004 Apr; 46(4):230-8. PubMed ID: 15077700
[TBL] [Abstract][Full Text] [Related]
2. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
[TBL] [Abstract][Full Text] [Related]
3. Beyond executive function: non-executive cognitive abilities in individuals with PKU.
Janzen D; Nguyen M
Mol Genet Metab; 2010; 99 Suppl 1():S47-51. PubMed ID: 20123470
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive assessment of neurocognitive and psychological functioning in adults with early-treated phenylketonuria.
Clocksin HE; Abbene EE; Christ S
J Int Neuropsychol Soc; 2023 Aug; 29(7):641-650. PubMed ID: 36134437
[TBL] [Abstract][Full Text] [Related]
5. Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population.
Gassió R; Artuch R; Vilaseca MA; Fusté E; Boix C; Sans A; Campistol J
Dev Med Child Neurol; 2005 Jul; 47(7):443-8. PubMed ID: 15991863
[TBL] [Abstract][Full Text] [Related]
6. Interhemispheric interaction during childhood: II. Children with early-treated phenylketonuria.
Banich MT; Passarotti AM; White DA; Nortz MJ; Steiner RD
Dev Neuropsychol; 2000; 18(1):53-71. PubMed ID: 11143804
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
[TBL] [Abstract][Full Text] [Related]
8. Interhemispheric transfer in children with early-treated phenylketonuria.
Gourovitch ML; Craft S; Dowton SB; Ambrose P; Sparta S
J Clin Exp Neuropsychol; 1994 Jun; 16(3):393-404. PubMed ID: 7929707
[TBL] [Abstract][Full Text] [Related]
9. Lateralized deficits in visual attention in males with developmental dopamine depletion.
Craft S; Gourovitch ML; Dowton SB; Swanson JM; Bonforte S
Neuropsychologia; 1992 Apr; 30(4):341-51. PubMed ID: 1603297
[TBL] [Abstract][Full Text] [Related]
10. A volumetric study of basal ganglia structures in individuals with early-treated phenylketonuria.
Bodner KE; Aldridge K; Moffitt AJ; Peck D; White DA; Christ SE
Mol Genet Metab; 2012 Nov; 107(3):302-7. PubMed ID: 23006929
[TBL] [Abstract][Full Text] [Related]
11. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
12. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data.
Price CC; Jefferson AL; Merino JG; Heilman KM; Libon DJ
Neurology; 2005 Aug; 65(3):376-82. PubMed ID: 16087901
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review.
Brumm VL; Azen C; Moats RA; Stern AM; Broomand C; Nelson MD; Koch R
J Inherit Metab Dis; 2004; 27(5):549-66. PubMed ID: 15669671
[TBL] [Abstract][Full Text] [Related]
14. Executive function in phenylketonuria (PKU): Insights from the Behavior Rating Inventory of Executive Function (BRIEF) and a large sample of individuals with PKU.
Christ SE; Clocksin HE; Burton BK; Grant ML; Waisbren S; Paulin MC; Bilder DA; White DA; Saville C
Neuropsychology; 2020 May; 34(4):456-466. PubMed ID: 32202818
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria.
Arnold GL; Kramer BM; Kirby RS; Plumeau PB; Blakely EM; Sanger Cregan LS; Davidson PW
Acta Paediatr; 1998 May; 87(5):565-70. PubMed ID: 9641741
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels.
González García MB; Conde-Guzon P; Alcalde Martín C; Conde-Guzon MJ; Velasco Zúñiga R
Arch Argent Pediatr; 2017 Jun; 115(3):267-273. PubMed ID: 28504493
[TBL] [Abstract][Full Text] [Related]
17. Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics.
Feldmann R; Denecke J; Pietsch M; Grenzebach M; Weglage J
Pediatr Res; 2002 Jun; 51(6):761-5. PubMed ID: 12032274
[TBL] [Abstract][Full Text] [Related]
18. Executive functioning, memory, and learning in phenylketonuria.
Channon S; German E; Cassina C; Lee P
Neuropsychology; 2004 Oct; 18(4):613-20. PubMed ID: 15506828
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory control in children with phenylketonuria.
Christ SE; Steiner RD; Grange DK; Abrams RA; White DA
Dev Neuropsychol; 2006; 30(3):845-64. PubMed ID: 17083296
[TBL] [Abstract][Full Text] [Related]
20. Executive functioning and speed of processing in phenylketonuria.
Channon S; Mockler C; Lee P
Neuropsychology; 2005 Sep; 19(5):679-686. PubMed ID: 16187886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
